GlassScriptPhysician profile
Gary M Sherman
NPI 1669432027
$5,374.88
in general payments reported to CMS, 2019-2025
26 companies · $202 in 2025
The $202 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $747 · 2020: $2,034 · 2021: $172 · 2022: $112 · 2023: $2,087 · 2024: $21.96 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,547 · Food and Beverage: $764.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,546.92 |
| Food and Beverage | $763.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,830.62 | 2020-2023 | |
| Supreme Orthopedic Systems, LLC | $1,220.68 | 2019-2023 | |
| Endo Pharmaceuticals INC. | $218.58 | 2019-2021 | |
| Linvatec Corporation | $163.32 | 2025 | |
| Stryker Corporation | $138.50 | 2019-2023 | Blueprint Patient Specific Instrumentation, Tornier Perform Reversed Glenoid, Aequalis Perform Reversed |
| Zimmer Biomet Holdings, INC. | $129.29 | 2019-2020 | |
| Dynasplint Systems INC. | $105.82 | 2020 | |
| Ferring Pharmaceuticals INC. | $96.15 | 2019-2022 | |
| Pacira Therapeutics, INC. | $63.33 | 2019-2021 | |
| Ermi LLC | $62.06 | 2019-2021 | |
| Bioventus LLC | $44.93 | 2022-2023 | Exogen Ultrasound Bone Healing System |
| Abbott Laboratories | $44.41 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $37.56 | 2021-2023 | |
| Biocomposites INC | $23.85 | 2019 | |
| Orthofix Medical, INC. | $23.41 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $21.96 | 2024 | Zilretta, Iovera |
| Heron Therapeutics, INC. | $19.43 | 2022 | |
| Solventum Corporation | $19.33 | 2025 | Activ.A.C. |
| Amgen INC. | $19.13 | 2025 | Krystexxa |
| Depuy Synthes Sales INC. | $16.42 | 2021 | |
| Ibsa Pharma INC. | $16.37 | 2021 | |
| Medtronic USA, INC. | $15.18 | 2020 | |
| Horizon Therapeutics Plc | $13.07 | 2020 | |
| Wright Medical Technology, INC. | $13.06 | 2019 | |
| Smith+Nephew, INC. | $12.70 | 2019 | |
| Fidia Pharma USA INC. | $5.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Sherman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.